Latest news
Riding the Tide, Staying True to Purpose: Decoding the Era’s Answer to the Rise of Domestic Pharmaceutical Companies - MoomooMoomoo · Sat, 08 Aug 2026 09:45:17 GMTInnoCare Pharma (SEHK:9969) Following Breakthrough Therapy News And The Undervalued Narrative - simplywall.stsimplywall.st · Fri, 07 Aug 2026 06:34:39 GMTInnoCare Announces Orelabrutinib in Combination with Mesutoclax Granted Breakthrough Therapy Designation in China - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 02:48:00 GMTBreakthrough Psoriasis Data For Oral TYK2 Drug Might Change The Case For Investing In InnoCare Pharma (SEHK:9969) - simplywall.stsimplywall.st · Wed, 29 Jul 2026 11:22:54 GMTOak Hill Bio merges with RA Capital SPAC; InnoCare’s TYK2 drug hits in Phase 3 - Endpoints NewsEndpoints News · Tue, 28 Jul 2026 07:00:00 GMTInnoCare Pharma Says Fadeucravacitinib (ICP-488) Phase III Registrational Trial Met Primary Endpoint - TradingViewTradingView · Mon, 27 Jul 2026 15:31:39 GMTInnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test - Fierce BiotechFierce Biotech · Mon, 27 Jul 2026 14:08:23 GMTChina’s Innocare says psoriasis oral drug shows ‘consistent treatment effect’ in late-stage trial - 101 WIXX101 WIXX · Mon, 27 Jul 2026 11:50:34 GMT